Researchers at the University of Colorado School of Medicine are hopeful new research could prevent up to 130,000 unneeded fine-needle aspiration (FNA) biopsies of thyroid nodules and subsequent surgeries each year in the United States by better understanding the genetic risk associated with thyroid cancer.
LENZ plans NDA submission for presbyopia eye drops this year, looks to launch in 2025
LENZ Therapeutics plans to seek FDA approval for its investigational eye drops for presbyopia, setting up the drug to compete against AbbVie’s Vuity and Orasis